Show simple item record

dc.contributor.authorSainz, Bruno
dc.contributor.authorAlcala, Sonia
dc.contributor.authorGarcia, Elena
dc.contributor.authorSanchez-Ripoll, Yolanda
dc.contributor.authorAzevedo, Maria M.
dc.contributor.authorCioffi, Michele
dc.contributor.authorTatari, Marianthi
dc.contributor.authorMiranda-Lorenzo, Irene
dc.contributor.authorHidalgo, Manuel
dc.contributor.authorGómez López, Gonzalo 
dc.contributor.authorCañamero, Marta
dc.contributor.authorErkan, Mert
dc.contributor.authorKleeff, Jörg
dc.contributor.authorGarcía-Silva, Susana
dc.contributor.authorSancho, Patricia
dc.contributor.authorHermann, Patrick C.
dc.contributor.authorHeeschen, Christopher
dc.contributor.otherUAM. Departamento de Medicina Preventiva y Salud Pública y Microbiologíaes_ES
dc.date.accessioned2016-08-04T15:47:56Z
dc.date.available2016-08-04T15:47:56Z
dc.date.issued2015-12-01
dc.identifier.citationGut 64.12 (2015): 1921-1935en_US
dc.identifier.issn0017-5749es_ES
dc.identifier.issn1468-3288 (on line)es_ES
dc.identifier.urihttp://hdl.handle.net/10486/672379
dc.descriptionThis is the peer reviewed version of the following article: Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment. Gut 64.12 (2015): 1921-1935 and which has been published in final form at http://dx.doi.org/10.1136/gutjnl-2014-308935en_US
dc.description.abstractOBJECTIVES: The tumour stroma/microenvironment not only provides structural support for tumour development, but more importantly it provides cues to cancer stem cells (CSCs) that regulate their self-renewal and metastatic potential. This is certainly true for pancreatic ductal adenocarcinomas (PDAC), where tumour-associated fibroblasts, pancreatic stellate cells and immune cells create an abundant paracrine niche for CSCs via microenvironment-secreted factors. Thus understanding the role that tumour stroma cells play in PDAC development and CSC biology is of utmost importance. DESIGN: Microarray analyses, tumour microarray immunohistochemical assays, in vitro co-culture experiments, recombinant protein treatment approaches and in vivo intervention studies were performed to understand the role that the immunomodulatory cationic antimicrobial peptide 18/LL-37 (hCAP-18/LL-37) plays in PDAC biology. RESULTS: We found that hCAP-18/LL-37 was strongly expressed in the stroma of advanced primary and secondary PDAC tumours and is secreted by immune cells of the stroma (eg, tumour-associated macrophages) in response to tumour growth factor-β1 and particularly CSC-secreted Nodal/ActivinA. Treatment of pancreatic CSCs with recombinant LL-37 increased pluripotency-associated gene expression, self-renewal, invasion and tumourigenicity via formyl peptide receptor 2 (FPR2)- and P2X purinoceptor 7 receptor (P2X7R)-dependent mechanisms, which could be reversed by inhibiting these receptors. Importantly, in a genetically engineered mouse model of K-Ras-driven pancreatic tumourigenesis, we also showed that tumour formation was inhibited by either reconstituting these mice with bone marrow from cathelicidin-related antimicrobial peptide (ie, murine homologue of hCAP-18/LL-37) knockout mice or by pharmacologically inhibiting FPR2 and P2X7R. CONCLUSIONS: Thus, hCAP-18/LL-37 represents a previously unrecognised PDAC microenvironment factor that plays a critical role in pancreatic CSC-mediated tumourigenesis.en_US
dc.description.sponsorshipCH: ERC Advanced Investigator Grant (Pa-CSC 233460), European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 256974 (EPC-TM-NET) and n° 602783 (CAM-PaC), the Subdirección General de Evaluación y Fomento de la Investigación, Fondo de Investigación Sanitaria (PS09/02129 & PI12/02643) and the Programa Nacional de Internacionalización de la I+D, Subprogramma: FCCI 2009 (PLE2009-0105; both Ministerio de Economía y Competitividad (es), Spain), BSJr: Rámon y Cajal Merit Award from the Ministerio de Economía y Competitividad, Spain and Clinic and Laboratory Integration Program (CLIP) grant from the Cancer Research Institute, NY, NY. MC: La Caixa Predoctoral Fellowshipen_US
dc.format.extent44 pag.es_ES
dc.format.mimetypeapplication/pdfen
dc.language.isoengen
dc.relation.ispartofGuten_US
dc.subject.otherAntibacterial peptideen_US
dc.subject.otherPancreatic canceren_US
dc.subject.otherStem cellsen_US
dc.subject.otherMacrophagesen_US
dc.titleMicroenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartmenten_US
dc.typearticleen
dc.subject.ecienciaMedicinaes_ES
dc.date.embargoend2016-12-01
dc.relation.publisherversionhttp://dx.doi.org/10.1136/gutjnl-2014-308935en
dc.identifier.doi10.1136/gutjnl-2014-308935en
dc.identifier.publicationfirstpage1921es_ES
dc.identifier.publicationissue12es_ES
dc.identifier.publicationlastpage1935es_ES
dc.identifier.publicationvolume64es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/256974en
dc.relation.projectIDGobierno de España. PS09/02129es_ES
dc.relation.projectIDGobierno de España. PI12/02643es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/233460en
dc.type.versioninfo:eu-repo/semantics/acceptedVersionen
dc.rights.accessRightsopenAccessen
dc.authorUAMSainz Anding, Bruno (264918)
dc.facultadUAMFacultad de Medicina


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record